Hikma Pharmaceutical | HIK - Capitaux D'Emprunt

Prix De L'Action
1,408.00
Variation Quotidienne
9.50 0.68%
Mensuellement
7.65%
Annuel
-29.81%
Q2 Prévisions
1,361.73




Capitaux D'Emprunt Changement Date
Almirall EUR 324.81M 61.32M 2025-12
argenx SE USD 35.57M 3.05M 2025-06
AstraZeneca USD 25.96B 177M 2026-03
Autolus Therapeutics Ltd USD 270.2M 18.26M 2025-12
Bayer EUR 31.83B 877M 2025-12
Fresenius EUR 10.8B 1.49B 2025-09
Galapagos EUR 5.19M 574K 2025-12
Genmab DKK 5.14B 5.01B 2025-12
GlaxoSmithKline GBP 14.01B 696M 2026-03
GRIFOLS EUR 8.47B 624.81M 2025-12
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Lonza CHF 3.88B 323M 2025-12
Merck EUR 10.73B 277M 2025-12
Orion EUR 110.6M 4.7M 2026-03
Recordati EUR 2.18B 89.51M 2025-09
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 13.84B 1.88B 2026-03
UCB EUR 2.18B 634M 2025-12